Related Experiment Video
Updated: Mar 9, 2026
07:51
Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
Published on: October 21, 2022
2.1K
[New approaches to ocular surface reconstruction beyond the cornea]
K Spaniol1, C Holtmann1, G Geerling1
1Augenklinik, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Summary
Conjunctival reconstruction uses various tissues, but limitations necessitate new therapies. Lab-engineered matrices and adult mucous membrane cells show promise for ocular surface repair.
Area of Science:
- Ophthalmology
- Tissue Engineering
- Regenerative Medicine
Background:
- Conjunctival reconstruction is crucial for ocular surface restoration.
- Current methods involve autologous conjunctiva, oral/nasal mucosa, and amniotic membranes.
- Existing techniques face limitations like availability and donor issues.
Purpose of the Study:
- To evaluate current and experimental tissue- and stem-cell-based approaches for conjunctival reconstruction.
- To identify limitations of existing methods and explore novel therapeutic strategies.
Main Methods:
- Review of current literature and presentation of original research findings.
- Evaluation of clinically applied and experimentally tested matrices.
- Assessment of conjunctival and mucous membrane cells for regenerative potential.
Main Results:
- Routine materials include autologous conjunctiva, oral/nasal mucosa, and amniotic membrane, each with drawbacks.
- Experimental matrices from extracellular matrix proteins, synthetic polymers, and decellularized conjunctiva show potential.
- Conjunctival and mucous membrane cells exhibit progenitor properties and goblet cell differentiation capacity.
Conclusions:
- Despite available matrices, new therapies are needed for conjunctival replacement due to limitations.
- Laboratory-produced matrices show promise for future clinical application.
- Expanded adult mucous membrane cells are a viable source for conjunctival tissue engineering, while other stem cell sources need further study.
